DAT-negative hemolytic anemia in a chronic lymphocytic leukemia patient treated with alemtuzumab

Leuk Lymphoma. 2007 Mar;48(3):625-7. doi: 10.1080/10428190601101019.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alemtuzumab
  • Anemia, Hemolytic / drug therapy*
  • Anemia, Hemolytic / etiology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications*
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab